Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

Who May Qualify: - Diagnosis of Idiopathic Pulmonary Fibrosis - Understanding and willingness to sign a written willing to sign a consent form document Who Should NOT Join This Trial: - Active infection - Active cancer - Chronic multisystem organ failure - Pregnancy - Clinically significant Abnormalities on pre-treatment laboratory evaluation - Medical condition that would (based on the opinion of the investigator) compromise patient's safety. - Continued drug abuse - Pre-menopausal women not using contraception - Previous organ transplant - Hypersensitivity to sulfur Always talk to your doctor about whether this trial is right for you.